Corrado Tarella Selected Research

Corrado Tarella Research Topics

Disease

19	Lymphoma (Lymphomas) 01/2022 - 09/2002
11	Neoplasms (Cancer) 11/2022 - 01/2002
7	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2019 - 09/2002
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 03/2005
6	B-Cell Lymphoma (Lymphoma, B Cell) 02/2021 - 01/2006
5	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2021 - 07/2003
5	Hodgkin Disease (Hodgkin's Disease) 11/2020 - 06/2003
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2022 - 11/2011
4	Residual Neoplasm 01/2020 - 04/2003
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2013 - 03/2005
3	Disease Progression 01/2022 - 02/2011
3	Pathologic Complete Response 01/2021 - 01/2002
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2020 - 01/2010
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2018 - 07/2012
2	Ovarian Epithelial Carcinoma 11/2022 - 01/2021
2	Cytopenia 11/2022 - 09/2005
2	COVID-19 01/2022 - 02/2021
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2015 - 01/2006
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2013 - 07/2006
2	Myocardial Infarction 04/2006 - 02/2006
2	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2004 - 01/2002
1	Infections 01/2022
1	Neutropenia 01/2022
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2022
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2022
1	Pleural Effusion (Pleural Effusions) 02/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2021
1	Dyspnea (Shortness of Breath) 02/2021
1	Chest Pain (Chest Pains) 02/2021
1	Cough 02/2021
1	Pneumonia (Pneumonitis) 02/2021
1	Hematologic Diseases (Blood Diseases) 01/2021
1	Monoclonal Gammopathy of Undetermined Significance 01/2021
1	Anemia 04/2020
1	Respiratory Insufficiency (Respiratory Failure) 04/2020
1	Thrombocytopenia (Thrombopenia) 04/2020
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Neuroinflammatory Diseases 01/2020
1	Melanoma (Melanoma, Malignant) 04/2015
1	Fibrosis (Cirrhosis) 10/2013
1	Polycythemia Vera 07/2013
1	Primary Myelofibrosis (Myelosclerosis) 07/2013
1	Hemolytic Anemia 04/2013
1	Wounds and Injuries (Trauma) 10/2012
1	Pilonidal Sinus (Pilonidal Cyst) 10/2012

Drug/Important Bio-Agent (IBA)

13	Rituximab (Mabthera)FDA Link 11/2019 - 07/2003
8	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 02/2006
5	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020 - 10/2007
4	Vincristine (Oncovin)FDA LinkGeneric 10/2018 - 10/2007
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2017 - 01/2002
3	Pharmaceutical PreparationsIBA 11/2022 - 01/2005
3	Biological ProductsIBA 01/2022 - 02/2011
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2013
3	Prednisone (Sone)FDA LinkGeneric 02/2017 - 10/2007
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2022 - 01/2021
2	venetoclaxIBA 01/2022 - 01/2020
2	Vinblastine (Vinblastine Sulfate)FDA Link 11/2020 - 10/2018
2	Dacarbazine (DIC)FDA LinkGeneric 11/2020 - 10/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2018 - 06/2012
2	AntimetabolitesIBA 11/2018 - 11/2015
2	Methotrexate (Mexate)FDA LinkGeneric 11/2015 - 06/2004
2	CytokinesIBA 04/2015 - 02/2011
2	Alemtuzumab (Campath)FDA Link 10/2007 - 01/2006
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 04/2006 - 02/2006
2	fludarabineIBA 01/2006 - 01/2002
1	Azacitidine (5 Azacytidine)FDA Link 01/2022
1	AnthracyclinesIBA 01/2022
1	Dasatinib (BMS 354825)FDA Link 02/2021
1	dimemorfan (AT 17)IBA 02/2021
1	Tyrosine Kinase InhibitorsIBA 02/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 11/2020
1	Filgrastim (Neupogen)FDA Link 01/2020
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2019
1	Calcineurin InhibitorsIBA 11/2018
1	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2015
1	Etoposide (VP 16)FDA LinkGeneric 11/2015
1	Surface Antigens (Surface Antigen)IBA 04/2015
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 04/2015
1	Melanoma-Specific AntigensIBA 04/2015
1	AntigensIBA 04/2015
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2015
1	AgglutininsIBA 04/2013
1	Bendamustine Hydrochloride FDA Link 04/2013
1	Sorafenib (BAY 43-9006)FDA Link 07/2012

Therapy/Procedure

25	Drug Therapy (Chemotherapy) 01/2022 - 09/2002
16	Therapeutics 11/2022 - 06/2003
8	Radiotherapy 01/2022 - 09/2005
6	Autologous Transplantation 04/2008 - 09/2002
5	Stem Cell Transplantation 01/2021 - 03/2005
4	Immunotherapy 10/2021 - 06/2011
4	Bone Marrow Transplantation (Transplantation, Bone Marrow) 02/2015 - 03/2005
3	Salvage Therapy 11/2022 - 01/2005
3	Homologous Transplantation 03/2005 - 01/2002
2	Aftercare (After-Treatment) 01/2022 - 01/2020
2	Transplantation 01/2021 - 01/2002
1	Kidney Transplantation 01/2021
1	Chemoradiotherapy 04/2020
1	Hematopoietic Stem Cell Transplantation 08/2013